Literature DB >> 12657201

Protective effect of n-acetylcysteine in a model of influenza infection in mice.

D Ungheri1, C Pisani, G Sanson, A Bertani, G Schioppacassi, R Delgado, M Sironi, P Ghezzi.   

Abstract

Reactive oxygen intermediates (ROI) and cytokines, particularly tumor necrosis factor (TNF) have been implicated in the pathogenesis of influenza. Using a murine model of influenza, we have studied the levels of TNF, interleukin 6 (IL-6) and of superoxide-generating xanthine oxidase (XO). Mice infected intranasally with influenza virus APR/8 had high levels of XO, TNF and IL-6 in the broncoalveolar lavage, as early as 3 d after infection. XO was elevated also in serum and lung tissue. Administration of the antioxidant N-acetylcysteine (NAC,1 g/kg per day, orally) significantly decreased the mortality in infected mice, indicating a role for RO1 in the lethality associated with influenza infection.

Entities:  

Year:  2000        PMID: 12657201

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  13 in total

Review 1.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Role of glutathione in immunity and inflammation in the lung.

Authors:  Pietro Ghezzi
Journal:  Int J Gen Med       Date:  2011-01-25

3.  N-acetylcysteine lacks universal inhibitory activity against influenza A viruses.

Authors:  Mutien-Marie O Garigliany; Daniel J Desmecht
Journal:  J Negat Results Biomed       Date:  2011-05-09

Review 4.  Intracellular redox state as target for anti-influenza therapy: are antioxidants always effective?

Authors:  Rossella Sgarbanti; Donatella Amatore; Ignacio Celestino; Maria Elena Marcocci; Alessandra Fraternale; Maria Rosa Ciriolo; Mauro Magnani; Raffaele Saladino; Enrico Garaci; Anna Teresa Palamara; Lucia Nencioni
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 5.  Antioxidant therapy as a potential approach to severe influenza-associated complications.

Authors:  Noboru Uchide; Hiroo Toyoda
Journal:  Molecules       Date:  2011-02-28       Impact factor: 4.411

6.  Inhibitory effect of glutathione on oxidative liver injury induced by dengue virus serotype 2 infections in mice.

Authors:  Juan Wang; Yanlei Chen; Na Gao; Yisong Wang; Yanping Tian; Jiangman Wu; Junlei Zhang; Junping Zhu; Dongying Fan; Jing An
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

7.  Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients.

Authors:  Jan De Backer; Wim Vos; Cedric Van Holsbeke; Samir Vinchurkar; Rita Claes; Paul M Parizel; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-11-22

Review 8.  Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.

Authors:  Sandra Söderholm; Yu Fu; Lana Gaelings; Sergey Belanov; Laxman Yetukuri; Mikhail Berlinkov; Anton V Cheltsov; Simon Anders; Tero Aittokallio; Tuula A Nyman; Sampsa Matikainen; Denis E Kainov
Journal:  Viruses       Date:  2016-09-29       Impact factor: 5.048

9.  Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.

Authors:  Lotfollah Davoodi; Seyed Mohammad Abedi; Ebrahim Salehifar; Reza Alizadeh-Navaei; Hamed Rouhanizadeh; Ghasemali Khorasani; Seyed Jalal Hosseinimehr
Journal:  Int J Clin Pract       Date:  2020-07-17       Impact factor: 3.149

10.  Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Prog Cardiovasc Dis       Date:  2020-02-12       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.